Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
School of Medicine, Tsinghua University, Beijing, 100084, China.
Orphanet J Rare Dis. 2024 May 16;19(1):201. doi: 10.1186/s13023-024-03177-y.
Chronic enteropathy associated with SLCO2A1 gene is a rare intestinal disease caused by loss-of-function SLCO2A1 mutations, with clinical and genetic characteristics remaining largely unknown, especially in Chinese patients. This study aims to reveal clinical and genetic features of Chinese CEAS patients, highlighting the previously unreported or unemphasized characteristics.
We enrolled 12 Chinese patients with chronic enteropathy associated with SLCO2A1 gene admitted to Peking Union Medical College Hospital from January 2018 to December 2022. Clinical and genetic data of these patients were collected and analyzed.
58.3% of patients were male, who also had primary hypertrophic osteoarthropathy, whereas female patients did not have primary hypertrophic osteoarthropathy. Apart from common symptoms associated with anemia and hypoalbuminemia, abdominal pain, ileus, diarrhea, and hematochezia were present. 4 of the 5 female patients had early-onset amenorrhea, though the causal relationship remained to be clarified. Endoscopy and computed tomography enterography revealed that lesions can occur in any part of the digestive tract, most commonly in the ileum. Pathology showed multiple superficial ulcers with adjacent vascular dilatation, and loss of SLCO2A1 expression, particularly in gastrointestinal vascular endothelial cells. Genetic analysis confirmed SLCO2A1 mutations in all patients and identified 11 new SLCO2A1 variants for CEAS.
This study reports new clinical, pathological, and genetic findings in 12 Chinese patients with chronic enteropathy associated with SLCO2A1 gene. This study provides insights into the pathogenesis of this disease. However, studies with larger sample sizes and more in-depth mechanism research are still required.
由 SLCO2A1 基因突变导致的功能丧失引起的慢性肠病相关综合征(CEAS)是一种罕见的肠道疾病,其临床和遗传特征在很大程度上尚不清楚,尤其是在中国患者中。本研究旨在揭示中国 CEAS 患者的临床和遗传特征,强调以前未报道或未强调的特征。
我们纳入了 2018 年 1 月至 2022 年 12 月期间北京协和医院收治的 12 例 SLCO2A1 基因相关慢性肠病患者,收集并分析了这些患者的临床和遗传数据。
58.3%的患者为男性,同时患有原发性肥大性骨关节病,而女性患者则无原发性肥大性骨关节病。除了与贫血和低白蛋白血症相关的常见症状外,还存在腹痛、肠梗阻、腹泻和血便。5 例女性患者中有 4 例存在早发性闭经,但因果关系尚待澄清。内镜和计算机断层扫描肠造影显示病变可发生在消化道的任何部位,最常见于回肠。病理表现为多发性浅表溃疡伴相邻血管扩张,SLCO2A1 表达缺失,特别是在胃肠道血管内皮细胞中。基因分析证实所有患者均存在 SLCO2A1 突变,并发现 11 种新的 SLCO2A1 变异与 CEAS 相关。
本研究报告了 12 例中国 SLCO2A1 基因相关慢性肠病患者的新的临床、病理和遗传发现。本研究为该疾病的发病机制提供了新的认识。然而,仍需要更大样本量和更深入的机制研究。